This is due to the increase in IFN-γ from CD8+ T cells [101], as also demonstrated in vivo in IL-10 transgenic mice with stimulated CD8+ T cells, resulting in the limited growth of immunogenic tumor cells [102]. The gene discussed is IL10; the disease is neoplasm.